Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Acq. announced
Director departure
Nuvation Bio Inc. (NUVB) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update"
05/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/04/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/16/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/15/2023 10-K Annual Report for the period ended December 31, 2022
03/15/2023 8-K Quarterly results
Docs: "Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update"
03/02/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Petition of Nuvation Bio Inc. Pursuant to 8 Del. C. § 205",
"Petition of Nuvation Bio Inc. Pursuant to 8 Del. C. § 205"
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/09/2023 SC 13G/A FMR LLC reports a 12.1% stake in NUVATION BIO INC
12/23/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Corporate Slide Presentation"
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 8-K Quarterly results
08/26/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
08/01/2022 8-K Results of Operations and Financial Condition, Cost Associated with Exit or Disposal Activities, Other Events &nbs...
Docs: "Nuvation Bio Announces Discontinuation of NUV-422 Clinical Development Program"
06/23/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/17/2022 8-K Quarterly results
05/09/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/09/2022 8-K Quarterly results
04/11/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/08/2022 EFFECT Form EFFECT - Notice of Effectiveness:
04/04/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/02/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/28/2022 8-K Quarterly results
02/28/2022 10-K Annual Report for the period ended December 31, 2021
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/01/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy